Signaling control of mRNA translation in cancer pathogenesis. - Wikidata - awgldk - TriplyDB

Signaling control of mRNA translation in cancer pathogenesis.

Signaling control of mRNA translation in cancer pathogenesis.

http://www.wikidata.org/entity/Q35750101

about

ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2 The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control.Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3)Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for ribosome biogenesis and cell proliferation Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models Structural basis for translational inhibition by the tumour suppressor Pdcd4 Systematic identification and functional screens of uncharacterized proteins associated with eukaryotic ribosomal complexes.c-Jun-mediated anticancer mechanisms of tylophorine Posttranscriptional regulation of p53 and its targets by RNA-binding proteins Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response.The role of PKR/eIF2α signaling pathway in prognosis of non-small cell lung cancer Novel 5'TOPmRNAs regulated by ribosomal S6 kinase are important for cardiomyocyte development: S6 kinase suppression limits cardiac differentiation and promotes pluripotent cells toward a neural lineage.Proteomic characterization of evolutionarily conserved and variable proteins of Arabidopsis cytosolic ribosomes.Bioinformatic screening of human ESTs for differentially expressed genes in normal and tumor tissues.Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway.Palmitoylation of oncogenic NRAS is essential for leukemogenesis.Mitomycin C inhibits ribosomal RNA: a novel cytotoxic mechanism for bioreductive drugs.Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma.Post-GWAS functional characterization of susceptibility variants for chronic lymphocytic leukemia.Extensive translatome remodeling during ER stress response in mammalian cells Nucleolar adaptation in human cancer The role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancers.Activation of the mTOR signaling pathway in breast cancer MCF‑7 cells by a peptide derived from Porphyra yezoensis.eIF4E as a control target for viruses.The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis.Increased susceptibility of breast cancer cells to stress mediated inhibition of protein synthesis.Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer.Alternatively spliced isoforms of the human elk-1 mRNA within the 5' UTR: implications for ELK-1 expression Inhibitors of the mammalian target of rapamycin.Identification of global alteration of translational regulation in glioma in vivo The amino acid sensitive TOR pathway from yeast to mammals.Old drug, new target: ellipticines selectively inhibit RNA polymerase I transcription.Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines Phosphorylated 4EBP1 is associated with tumor progression and poor prognosis in Xp11.2 translocation renal cell carcinoma.

P2860

Q21142651-56132277-7C53-4C48-BF5C-D9F85EDE6065 Q24293101-8CA547BC-4C53-4AE1-ABB1-52B2B283A23D Q24297576-D55A02AD-DFF8-4690-AB26-BAA207D591B1 Q24304179-795078A4-C654-476C-9934-6487166A65F4 Q24306650-1BD8395B-61F3-431D-9DCF-B918BA78CFEA Q24310054-37D530EE-7B6D-4FF6-997A-1D419D061A11 Q24550891-21241F1D-55B3-4E3C-90ED-DEB345B6CDE6 Q26822694-5FAD3F36-E041-4920-BE60-BAC7E3A92934 Q27321080-D2720215-FDCB-450C-AC14-C34CF9D473B3 Q27653464-D1CEC255-9535-4C90-ACEE-F60152FC573F Q27939264-8F4E43FE-F5AF-4879-AE95-B642EF35AA06 Q28285030-924B6DAA-23EA-43FA-88F4-5312FCAA6AA0 Q28387511-1FAB6BA1-660C-45A6-8401-3D0B11693F30 Q28513144-3659D339-6255-4508-A9D8-D1458B53B03D Q28513487-2ED3DE70-4896-4411-B935-79E8B9362443 Q28742943-C248E5D1-5E5C-4626-8E0C-191CC795F992 Q30418844-5E69FA5F-AE20-4D64-B243-8EE088469054 Q31150076-27F850B4-4E25-436B-8A65-6EEE49A70040 Q33241205-0130BD6C-1EAA-4956-9CBD-2A606D533C65 Q33274677-3868A23E-E4D1-4904-8C6C-319A49831F74 Q33831975-CAE0163E-52FD-444A-B589-19A7946E4894 Q33839862-E846B8BF-0894-4646-992E-27C5E0C07E2B Q33911220-EE68DE04-68A4-4C5C-80D0-240867F2156D Q34105105-DCE7F9FE-B9D0-4028-8BDA-D7E70D3871FD Q34123783-CC4627C4-8D00-4142-8225-ED990FBFA528 Q34264546-F3D10CEA-467D-4F96-9D33-26A8A58B21CE Q34452742-0F813EBA-845D-4244-88D0-8F5090FE981E Q34559250-C0CDF661-7AA3-4326-9475-02BB69B38610 Q34626081-A2ACD1CF-EEC6-43E9-A303-4EF441FEB921 Q35160012-F6465401-AB47-43E9-87FA-BA40761BA188 Q35447328-A0C53614-3EC2-40A8-BE1D-C66B5D05CE35 Q35560439-588F56CF-D594-45A8-9801-E99CD7B17A6F Q35862470-47DFF88F-9E2E-4F41-972A-797A520D89F3 Q35945452-2888CC5E-3624-4002-B51D-547FCD0BAAE5 Q36099427-40B7C8AA-303B-4983-AB4F-76AEC32DBB28 Q36295318-D82517F4-A7CC-44F5-8918-5BDD155280AB Q36473396-10259BCD-7B84-474A-80C4-3F2A6B325221 Q36620686-CA2EF943-506B-4D3E-BEA0-922047078064 Q36731407-87F1D8EA-60FD-43DD-BE2A-1368D6D0A84C Q36741509-693709AC-1334-48D5-99FF-1824EC81C3C3

P2860

Signaling control of mRNA translation in cancer pathogenesis.

http://www.wikidata.org/entity/Q35750101

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Signaling control of mRNA translation in cancer pathogenesis.

@ast

Signaling control of mRNA translation in cancer pathogenesis.

@en

type

label

Signaling control of mRNA translation in cancer pathogenesis.

@ast

Signaling control of mRNA translation in cancer pathogenesis.

@en

prefLabel

Signaling control of mRNA translation in cancer pathogenesis.

@ast

Signaling control of mRNA translation in cancer pathogenesis.

@en

P1433

Q35750101-C048AE18-9BD3-4EBE-A1D2-DF35D835F2FB

P1476

Q35750101-6B31AAAC-C436-4F25-8D6A-C047D5CB67DF

P2093

Q35750101-0CB36C37-9E67-409E-B130-CB1070ECB4F0

Q35750101-F5553638-DFEA-4082-B8C2-7B61AE9A7130

P2860

Q35750101-00DABAA0-4CA7-42C0-888D-0103274AE50C

Q35750101-140B8ABF-88E6-4752-BC0D-D4956A9CB184

Q35750101-4D16D41C-6F3D-4EFD-B3CF-5C485C2DC5C7

Q35750101-4E556649-B967-4CE8-BC7F-987E17DAD51C

Q35750101-50EC2A73-2180-4082-BCA6-219555F78F0A

Q35750101-58588FF6-B6C8-48C6-846D-E102020062CD

Q35750101-5E583064-BDDC-4BB2-B747-DB0D1EB7BE29

Q35750101-6B0C2AB2-7CFD-4FFC-A203-E3DA8BABA2A0

Q35750101-6D9E9B67-094E-4D81-BA18-895F48C338AD

Q35750101-6DC60002-1714-47BE-A00D-C388D4424725

P2888

Q35750101-F30A9362-2CF6-47A5-AD97-AAC191881198

P304

Q35750101-7BA30ABF-810A-47E9-B355-5DFC49387230

P31

Q35750101-26D7E90F-588E-48F4-8A81-B07DC95D2135

P356

Q35750101-258CBB9D-F6C1-4587-BFEC-57C0C80710F0

P407

Q35750101-B7482232-646E-4BC8-B0DC-6388F2EDD4DA

P433

Q35750101-6B2CAB30-829E-4BEF-81AA-95C808F26301

P478

Q35750101-07467603-A052-449C-8C2E-DD33CB559A50

P50

Q35750101-272F1BB7-632E-4F7C-954C-F00CB8537CDE

Q35750101-4B8635FC-4535-4F87-A164-5D7A982EB995

P577

Q35750101-F427CD2C-9DED-40FE-A0F6-F1577F852B9F

P5875

Q35750101-A15CEE71-3724-4498-888E-DBEEC942ACAB

P698

Q35750101-DB1FE2A5-DF49-4566-8113-FAB92E45E571

P356

P1433

P1476

Signaling control of mRNA translation in cancer pathogenesis.

@en

P2093

Eric C Holland

http://www.w3.org/2001/XMLSchema#string

George Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent

Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells

Molecular mechanisms of translation initiation in eukaryotes

Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation.

The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.

eIF4E expression in tumors: its possible role in progression of malignancies.

The role of the 5' untranslated region of an mRNA in translation regulation during development.

An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice.

P2888

P304

3138-3144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1207590

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Pier Paolo Pandolfi

Nahum Sonenberg

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8608530

http://www.w3.org/2001/XMLSchema#string

P698

15094763

http://www.w3.org/2001/XMLSchema#string